Guangzhou Blood Center   Report issue

Academic/Hospital
Founded: Guangzhou China

Organization Overview

First Clinical Trial
2016
NCT03727230
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Guangzhou Blood Center

Active Ingredients

Drugs in Other Trials (1)

allogeneic blood cells (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1